Split History
PVCT split history picture
PVCT (PVCT) has 1 split in our PVCT split history database. The split for PVCT took place on April 11, 2002. This was a 1 for 300 reverse split, meaning for each 300 shares of PVCT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 3.33333333333333 share position following the split.

When a company such as PVCT conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PVCT split history from start to finish, an original position size of 1000 shares would have turned into 3.33333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PVCT shares, starting with a $10,000 purchase of PVCT, presented on a split-history-adjusted basis factoring in the complete PVCT split history. PVCT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/01/2012
End date: 09/27/2022
Start price/share: $0.65
End price/share: $0.05
Dividends collected/share: $0.00
Total return: -92.00%
Average Annual Total Return: -22.33%
Starting investment: $10,000.00
Ending investment: $800.08
Years: 9.99
Provectus Biopharmaceuticals is a development-stage biopharmaceutical company that is primarily engaged in developing pharmaceuticals for oncology and dermatology indications. Co. focuses on developing its two prescription drug candidates, PV-10 and PH-10. Co. is developing PV-10 for treatment of several life threatening cancers including metastatic melanoma, liver cancer, and breast cancer. Co. is developing PH-10 to provide treatment of chronic severe skin afflictions such as psoriasis and atopic dermatitis, a type of eczema. All of Co.'s prescription drug candidates are in either the pre-clinical or clinical trial stage. According to our PVCT split history records, PVCT has had 1 split.
Date Ratio
04/11/20021 for 300
PVCT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

Q Split History
QGEN Split History
QLTI Split History
RARE Split History
RCKT Split History
RCPI Split History
RDNT Split History
RDY Split History
REPH Split History
RGLS Split History

Email EnvelopeFree PVCT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
TD Holdings, Inc. (GLG )
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PVCT Insider Buying

PVCT Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.